CNS delivery of the secreted amyloid precursor protein ectodomain APPsa: Effects on brain physiology and therapeutic potential for Alzheimer’s disease – nEUAPPs
Project coordination
Ulrike C. MÜLLER (Institute for Pharmacy and Moecular Biotechnology; University of Heidelberg) – ERANET_u.mueller@urz.uni-hd.de
The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.
Partner
ARD MIRCen/CEA - Association Robert Debré pour la recherche medicale
N/A Molecular Biotechnology and Gene Therapy; Paul-Ehrlich-Institut
N/A Institute for Pharmacy and Moecular Biotechnology; University of Heidelberg
N/A Department of Human Genetics; Katholic University of Leuven
Help of the ANR 232,960 euros
Beginning and duration of the scientific project:
April 2013
- 36 Months
